Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re one of the millions of adults worldwide who heard about Novo Nordisk’s ...

GLP-1 medications have exploded in popularity over the past few years, and it’s easy to see why. They work. People lose ...

A new research study provides real-world evidence that deprescribing glucose-lowering medications is both feasible and safe when patients with type 2 diabetes receive lifestyle-informed care in ...

A new research study provides real-world evidence that deprescribing glucose‑lowering medications is both feasible and safe when patients with type 2 diabetes receive lifestyle‑informed care in ...

A new clinical trial from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one ...

In the United States, over 30 million people suffer from diabetes, while nearly 98 million are classified as pre-diabetic. Unfortunately, rather than addressing the fundamental lifestyle factors that ...

Older adults with type 2 diabetes face a difficult trade-off: they are among the most vulnerable to medication-related harms yet are often underrepresented in the clinical trials that guide treatment ...

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week ...

Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked ...

The golden years should bring freedom from health worries, yet millions of seniors find their diabetes medications becoming less effective or causing dangerous side effects as they age. What worked ...